Business · 1 sources covering this

Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug

CDSCO expert panel grants waiver for 920 mg Ocrelizumab, subject to Roche conducting a Phase 4 clinical trial in the Indian population for proposed indications

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug
CDSCO expert panel grants waiver for 920 mg Ocrelizumab, subject to Roche conducting a Phase 4 clinical trial in the Indian population for proposed indications
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/2d67ab60a0fc9e5bd5d72d5dccc7719dd4aec7e6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug"></iframe>

Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug

How 1 sources are covering this

Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug

More from Business

Lodha Developers gains 40% in three months; brokerages see more upside

Influencer Swatantra Bhardwaj detained after 'bragging' he 'cracked the skull' of CJP protester's father

Zollner enters India with Avalon JV, to invest ₹1,000 crore in TN unit

RenewBuy-InsuranceDekho merged entity plans to deepen presence across India

Reader

Trust & legal

Across the network